Abstract
Information about the health status of newborns from mothers infected with the SARS-COV-2 coronavirus is few and contradictory, and there is practically no information on hemocoagulation disorders in such children in the available literature. Meanwhile, hemostasis disorders are one of the most urgent problems in neonatology. The importance of the stated topic is due to the potential risk of developing life-threatening conditions due to possible violations of the functions of vital organs, severe hypoxia resulting from massive blood loss. The aim of our study was to study the features of hemocoagulation disorders in newborns from mothers with coronavirus infection caused by SARS-CoV-2 (COVID-19). Confirmation of COVID-19 infection was a positive PCR test - detection of SARS-CoV-2 coronavirus RNA detected in women during pregnancy (in the second trimester or immediately before childbirth). Clinical, laboratory, and biochemical research methods were used in the examination of children. It was revealed that a transmitted coronavirus infection in the second half of pregnancy and before childbirth, indirectly affecting the fetus through the uteroplacental blood flow, exacerbates microcirculatory disorders, which leads to more pronounced hemorrhagic disorders in the newborn. Conflict of interests. The authors declare that there is not conflict of interests
Sign-in/Register to access full text options 
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
